CLOVER HEALTH INVESTOR ALERT

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Clover Health To Contact Him Directly To Discuss Their Options

NEW YORK - (NewMediaWire) - February 04, 2021 - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating potential claims against Clover Health Investments, Corp. (“Clover Health” or the “Company”) (NASDAQ:CLOV).

If you suffered losses exceeding $50,000 investing in Clover Health stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/CLOV or call Faruqi & Faruqi partner James Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

There is no cost or obligation to you.

On January 7, 2021, Clover Health merged with SPAC Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) and began to trade under the symbol CLOV on NASDAQ.

Then, on February 4, 2021, Hindenburg Research released a report titled "Clover Health: How the ‘King of SPACs’ Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation[.]" The report alleged, among other things, that "Clover has not disclosed that its business model and its software offering, called the Clover Assistant, are under active investigation by the Department of Justice (DOJ), which is investigating at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals."

On this news, Clover Health’s stock price fell from $13.95 per share on February 3, 2021 to a closing price of $12.23 on February 4, 2021—a $1.72 or 12.33% drop.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.